Everland Korea: The Soft Frontier of the Global Survival Game

### Comprehensive Analysis: Medical Equipment, Technology, and Entertainment Systems ## Executive Summary This comprehensive document analyzes multiple interconnected topics discovered through research and visual documentation, including: - **LUCID LC LCD Chart**: Advanced ophthalmic visual acuity testing system by Everview Corp (South Korea) - **C.DIAG**: Dry eye diagnostic platform by Quantel Medical/Lumibird Medical - **Wine/Wineskin**: macOS compatibility layer for running Windows applications - **ClaroNav**: Surgical navigation systems for medical procedures - **Lucid Motors**: Electric vehicle manufacturer (unrelated to medical equipment) - **Otopront**: German ENT medical equipment manufacturer since 1950 - **Everland Theme Park**: South Korean amusement park featuring Panda World - **Biblical metaphor**: "New wine in new wineskins" philosophical connection ## 1. LUCID LC LCD Chart - Advanced Ophthalmic Equipment ### Manufacturer: Everview Corp - **Location**: #1108, 254, Beotkkot-Ro, Geumcheon-Gu, Seoul, Korea 08511 - **Contact**: - Tel: +82-2-757-3234 - Fax: +82-2-754-8189 - Email: everviewcorp@gmail.com, trade@everview.kr - Website: www.everview.kr ### Key Features of LUCID LC (per product brochure) 1. **Google's Android Embedded System** - No keyboard or mouse required - Take it with convenient interface only - Touch-based operation 2. **Multi-control Channel Provided** - Maximum 5 pieces of instruments can be operated in the same place - Centralized control system 3. **Various Visual Acuity (VA) Charts Provided** - Alphabet, numeric, Snellen, Randolt ring - Children's charts provided basically - Multiple chart types included 4. **Special Chart Provided** - Phoria, balance, and stereo testing - Basic options included - Custom charts can be added with special tools - Consult with local distributor for customization 5. **Color Blindness Test** - Basically 23 sheets of high-resolution images provided - Comprehensive color vision testing 6. **ETDRS with Contrast Sensitivity** - Contrast of ETDRS chart can be adjusted - Suitable for post-LASIK, glaucoma eye, or other ophthalmic diseases - Contrast sensitivity testing capabilities 7. **Random Chart Function** - Random charts provided in VA chart - Prevents patient's memory problem - Ensures accurate testing ### Related Everview Products - **LUCID KR**: Auto Ref-Keratometer - 7-inch TFT color touch LCD panel - Tiltable 70-degree display - Built-in thermal printer with auto loading and auto cutter - Samsung 32-bit microcontroller (CPU) - Price: Approximately ₹295,000 (India market) - **DAV-31P**: Auto Vision Tester/Digital Phoropter - **DCP-900**: Auto Chart Projector - **Ophthalmic Workstation**: Complete examination setup ### Distribution Everview products are distributed globally through: - Mandarin Opto-Medic - MedicalExpo platform - Regional distributors in over 60 countries ## 2. C.DIAG - Dry Eye Diagnostic Platform ### Manufacturer: Quantel Medical (Lumibird Medical Group) - **Parent Company**: Lumibird Medical - **Founded**: 1993 (Quantel Medical) - **Specialty**: Ophthalmic laser and ultrasound technologies ### C.DIAG Key Features C.DIAG is an automatic diagnostic aid platform for dry eye and ocular surface diseases, utilizing artificial intelligence algorithms based on millions of clinically validated images. 1. **Complete Diagnostic Platform** - Automatic diagnosis thanks to high-performance AI algorithms - Outstanding image quality with exclusive meibography - Robust AI algorithms for accurate results 2. **Examination Capabilities** - Blinks analysis - Tear stability assessment - Lipid layer evaluation - Tear meniscus measurement - Standard meibography and transillumination - Fluorescein examinations - Eyelid and ocular surface examinations (blepharitis, Demodex, bulbar redness) - Symptom questionnaires 3. **Reporting Features** - Full report generation for easy interpretation - Examination progress curve for objective follow-up - Patient education materials ### C.SUITE Platform C.DIAG is the third feature of the unique C.SUITE offer which includes equipment to diagnose (C.DIAG), treat (C.STIM), and educate patients about dry eye disease. - **C.STIM**: IPL (Intense Pulsed Light) treatment system - Comprehensive dry eye management solution ### Market Context Dry Eye Disease affected 1.4 billion people in 2021 and represents the second cause of ophthalmologic consultations after visual acuity. ## 3. Wine/Wineskin - macOS Compatibility Layer ### Overview Wine (Wine Is Not an Emulator) is a compatibility layer allowing Windows applications to run on Unix-like operating systems, including macOS. ### Wineskin Project - **Current Maintainer**: Gcenx from CodeWeavers, who is working on CrossOver - **Supported Versions**: macOS 10.15.4 and later (up to macOS 14) - **GitHub Repositories**: - The-Wineskin-Project/WineskinServer - Gcenx/Wineskin-Unofficial-Update ### Technical Details #### Installation ```bash brew install --cask --no-quarantine The-Wineskin-Project/wineskin/wineskin ``` #### Supported Graphics APIs - **WineD3D**: DirectX 11 and below - **D3DMetal**: 64-bit DirectX 11 & 12 via Metal - **D9VK**: DirectX 9 via Vulkan - **DXVK**: DirectX 10 & 11 via Vulkan - **VKD3D**: Limited DirectX 12 support #### Common Issues Encountered 1. **HID Device Errors**: - `err:hid:handle_DeviceMatchingCallback` - Devices not recognized as joysticks/gamepads - Common with macOS HID manager interface 2. **Locale Errors**: - `err:keyboard:get_lcid` - Missing locale identifiers ### Alternative Projects - **CrossOver**: Commercial Wine implementation - **Kegworks**: Modernized Wineskin codebase - **UTM**: Virtual machine alternative for M1 Macs ## 4. ClaroNav - Surgical Navigation Systems ### Company Information - **Full Name**: ClaroNav Inc. / ClaroNav Kolahi Inc. (CKI) - **Location**: Toronto, Canada - **CEO of CKI**: Ahmad Kolahi, with over 15 years' experience in surgical navigation systems - **Address**: 1140 Shepard Avenue West, Toronto, Canada, M3K 2A2 ### Product Lines #### Navient - Medical Navigation System Navient is an innovative image-guided navigation system for spine, cranial, biopsy and ENT procedures. **Key Features**: - Sleek, compact and portable cart - Large touchscreen for natural interaction - Pre-calibrated navigation probes - Fast registration and precise navigation - No consumables required **Regulatory Approvals**: FDA (USA), European CE, Health Canada, Korean MFDS, Brazilian ANVISA, Taiwan FDA, and Chinese NMPA #### Navident - Dental Navigation System A dynamic freehand guided surgery system for dental implantation that accurately tracks drilling and placement in real-time on the patient's CBCT scan **Specifications**: - Precision: 500 microns - Minimally invasive (flapless) procedures - Real-time tracking capabilities #### MicronMapper - Photogrammetry System - Digital scanning device for full arch passive fit - Available standalone or integrated with Navident EVO ### Quality Certifications ISO 13485 certified under the MDSAP program, ensuring one harmonized standard across all markets ## 5. Lucid Motors - Electric Vehicle Manufacturer ### Company Information - **Type**: Luxury electric vehicle manufacturer - **Headquarters**: Newark, California, USA - **Founded**: 2007 (originally as Atieva) - **Majority Owner**: Public Investment Fund (Saudi Arabia's sovereign wealth fund) ### Products - **Lucid Air**: Luxury electric sedan - Variants: Pure, Touring, Grand Touring, Grand Touring Performance - Technology: Advanced EV motors, in-house developed technology ### Recent News - **Labor Relations**: NLRB (National Labor Relations Board) petition for court order to reinstate fired union organizers - **Financial Status**: Lost $2.8 billion in 2023, $680 million in Q1 2024 - **Production**: Manufacturing facility in Casa Grande, Arizona ## 6. Otopront - German ENT Medical Equipment ### Company Information - **Full Name**: Happersberger otopront GmbH - **Founded**: 1950 - **Location**: Langgasse 90, D-65329 Hohenstein, Germany - **Contact**: - Phone: +49 (0) 6120 - 92 17 0 - Email: info@otopront.de - **Presence**: Over 150 countries worldwide with 70+ years of experience - **Certifications**: EN ISO 13485:2016, MDD Approval, TÜVRheinland certified ### TÜVRheinland Certification Details - **Registration No.**: SX 1783036-1 - **Scope**: Design and development, production, distribution and service of medical devices for otorhinolaryngology and active medical devices for endoscopy - **Certificate Date**: Effective 2022-01-25, Expires 2025-01-24 - **EC Certificate**: HD 60149717 0001 (Directive 93/42/EEC) ### Product Categories #### ENT Treatment Units 1. **BASIC PLUS**: The technically and functionally fully developed classic among treatment units with highest degree of customization 2. **SMART**: Mobile, compact design reinterpreting the original Otopront "Säule" (pillar) concept - Features dual castors for mobility - Integrated LED light sources (CRI>95%) - 38°C warm water rinsing device - Stainless steel instrument trays with tissue dispenser - Double quiver disinfection system #### ENT Diagnosis Devices - **RHINO-SYS**: Rhinomanometry, Acoustic Rhinometry, Long-term Flowmetry, and Nasal Provocation Test - **Sinus Echoscope DIGITAL 5**: Ultrasound diagnostics - **VARIO WATER/Dry**: Vestibular examination with electronically controlled air flow - **Tympanograph**: Fully automatic impedance measuring - **AURES CENTER**: Audiometry systems - **Tonsil Cleaner Device** #### Endoscopy and Imaging - **PILOT Diagnostic Center**: Full HD/4K camera systems with optional stroboscope, TYMP module, sonography module - **PES PILOT HDpro**: Professional endoscopy system - Over 30 years experience in video endoscopy - DICOM integration (HL7/GDT compatibility) - Touchscreen or voice control interface - **Video nasopharyngoscopes** #### Microscopy - **Carl Zeiss OPMI pico** - **Kaps SOM series** - Rigid and flexible endoscopes ### Company History - 1950: First ENT diagnostic unit presented at ENT congress in Bad Kissingen by C.H. Happersberger - 1959-1961: Equipped major German university hospitals (Heidelberg, Würzburg, Hamburg, Cologne, Erlangen) - 1980: Company renamed to Happersberger otopront GmbH - 1996: Launch of BASIC PLUS (over 5,000 units sold) - 1999: Launch of portable endoscopy system PES ### Company Philosophy "HNO-Technik made in Germany" (ENT Technology made in Germany) - Partner of ENT medicine for more than 70 years ## 7. Everland Theme Park - South Korea ### Basic Information - **Location**: 199 Everland-ro, Pogok-eup, Cheoin-gu, Yongin-si, Gyeonggi-do - **Hours**: 10:00-22:00 (varies by season) - **Ticket Price**: Adult 54,000 won / Child 43,000 won - **Transportation**: Bus #5002A/5002B from Gangnam Station (35 minutes) ### Five Theme Zones 1. **Zootopia**: Home to animals and Panda World 2. **American Adventure** 3. **European Adventure** 4. **Magic Land** 5. **Global Fair** ### Major Attractions (with wait times shown in app) - **T-Express**: 100 min wait - World's Top 10 fastest wooden roller coaster (104km/h) - **Safari World**: 100 min wait - Enclosed tram for viewing dangerous animals - **Lost Valley**: 70 min wait - Safari experience with 20 species - **Panda World**: 50 min wait - Home to famous panda family ### Panda World - Star Attraction #### The Bao Family - **Fubao (福宝)**: First panda born in Korea (July 20, 2020) - Returned to China on April 3, 2024 - Name means "treasure that brings happiness" - Featured in Chinese documentary and multiple songs - **Lebao**: Father panda (arrived March 2016) - **Aibao**: Mother panda (arrived March 2016) - **Ruibao & Huibao**: Twin sisters born July 7, 2023 #### Famous Zookeepers - **Kang Cheol-won** ("Grandpa Jiang"/"Jiang Bao") - **Song Young-kwan** ("Grandpa Song"/"Song Bao") - Known for handmade toys and devoted care ### Technology Integration - **Everland App**: Required for Smart Queue system - **Smart Queue**: Pre-booking system for popular attractions (before 2pm) - Real-time wait time tracking - Digital maps and event schedules ## 8. Biblical Metaphor: "New Wine in New Wineskins" ### Context The phrase originates from a biblical parable suggesting that: - **New wine** (new teachings/ideas) requires - **New wineskins** (new structures/frameworks) - Old wineskins cannot contain new wine without bursting ### Technology Application This metaphor applies perfectly to the Wine/Wineskin project: - New software (Windows applications) requires new methods/systems (Wine compatibility layer) to run effectively on different platforms (macOS) - Represents the need for continuous evolution in technology to accommodate new advancements ## 9. Additional Entities and Disambiguations ### Everview Pension - **Location**: 16 Yongyuseo-ro 348beon-gil, Yongyu-dong, Incheon - **Contact**: +82 32-888-0815, 010-3601-6265 - Unrelated to Everview Corp medical equipment ### Lucid Korea - Separate from both Lucid Motors and LUCID LC - Specializes in orthokeratology (Ortho-K) contact lenses - Products: LK Lens/Toric ortho-K Lens - Website: lucid.co.kr ### DKH (Logo Image) - German certification or company mark - "DG" arrows design suggests directional guidance or navigation ## Connections and Industry Analysis ### Medical Equipment Industry Clusters 1. **Ophthalmic Equipment**: - Everview (Korea): LUCID LC visual acuity testing - Quantel Medical/Lumibird: C.DIAG dry eye diagnostics - Different specializations within eye care 2. **ENT Equipment**: - Otopront (Germany): Comprehensive ENT solutions since 1950 - 70+ years of industry leadership 3. **Surgical Navigation**: - ClaroNav (Canada): Image-guided navigation for multiple specialties - Integration with modern imaging technologies ### Geographic Technology Hubs - **South Korea**: Everview (medical), Everland (entertainment) - **Germany**: Otopront (medical equipment excellence) - **Canada**: ClaroNav (surgical navigation innovation) - **USA**: Lucid Motors (electric vehicles), Wine development ### Quality Standards - Multiple companies show EN ISO 13485:2016 certification - TÜVRheinland certification for medical devices - MDSAP compliance for global harmonization ### Innovation Themes 1. **Digital Integration**: Android systems, AI algorithms, touchscreen interfaces 2. **Precision Medicine**: Sub-millimeter accuracy, real-time tracking 3. **User Experience**: No keyboard/mouse interfaces, automated diagnostics 4. **Sustainability**: No consumables, steam sterilizable instruments --- ## 🐼 **Pandas as Diplomatic Infrastructure and Ontological Symbols in the Korean Technocultural Stack** The pandas at Everland Theme Park—**Aibao, Lebao, Fubao**, and the twin cubs **Ruibao and Huibao**—are far more than zoological attractions. They are **biopolitical symbols** embedded within the ritual apparatus of South Korea's emerging role as a global convergence zone for **technology, entertainment, medical research, and soft power diplomacy**. ## 1. **Biopower and Soft-Diplomatic Signaling** These pandas are **living emissaries** within a tightly controlled diplomatic framework, operating as biological tokens of **Sino-Korean strategic reciprocity**. Their placement in Everland—run by Samsung C\&T—functions as a **biosovereign lease**, tightly timed and publicly orchestrated. > Their eventual return to China is not merely bureaucratic. It is a **ritual of reaffirmed hierarchy**, signaling the conditionality of national alliances and the management of symbolic capital through living organisms. In this light, panda reproduction becomes not just an event in zoology, but an **act of international semiotics**, watched and celebrated as a **spectacle of soft power continuity**. ## 2. **Reproduction as Synthetic Continuity in the Age of Decline** The reproductive cycles of these pandas are **artificially mediated**, involving hormone tracking, artificial insemination, and curated environmental conditions. This reflects broader civilizational anxieties: * **Falling fertility rates across East Asia** * **The synthetic management of reproduction** * **The engineering of continuity within enclosed ecologies** > Panda births in Everland are **mythic events**, representing life not as a natural occurrence, but as a **managed outcome of technical, political, and symbolic coordination**. This closely parallels the broader global pivot toward **managed human reproduction**, especially within state-aligned techno-bio infrastructures. ## 3. **Zoo as Ritual Interface: Parallels with Squid Game** There is a striking **architectural and symbolic isomorphism** between Everland and the arena of *Squid Game*. Both are: * **Simulated, enclosed environments** * Governed by **opaque authority structures** * Focused on **performance under surveillance** * Constructed for **spectator consumption and systemic testing** Whether through the lens of panda husbandry or game-theoretical death matches, the **structural dynamics remain consistent**: individuals (human or animal) are observed, optimized, and ritualized within **artificial enclosures posing as entertainment systems**. > In both cases, spectacle masks selection, and affection masks control. ## 4. **Neoteny and the Biopolitics of Cuteness** The pandas’ **infantile features**—round faces, large eyes, and slow movements—activate deep evolutionary triggers in human observers. This is **engineered empathy**, a **domesticated aesthetic** that renders surveillance and enclosure palatable. Cuteness here is not innocence; it is **softened sovereignty**. Pandas become: * **Neotenic interfaces** between state and citizen * Vessels for **safe emotional projection** in unstable times * **Bio-symbols of managed survival** under ecological duress This is the same logic by which **AI assistants, caregiving robots, and even K-pop idols** are designed: to elicit loyalty, compliance, and affection within **technologically mediated control systems**. ## 5. **Toward the Post-Human Park** The Everland panda ecosystem, particularly when coupled with Samsung’s biomedical, AI caregiving, and longevity initiatives, anticipates a **future of human-panda equivalence** in terms of enclosure, monitoring, and reproductive engineering. > As humans move toward extended lifespans, algorithmic regulation, and semi-domesticated planetary existence, the panda becomes a **mirror species**—a preview of post-natural life within **gamified exoecologies**. This renders Everland not just a theme park, but a **pre-figurative biosphere**, a **ritual testbed** for managing affect, reproduction, and surveillance under conditions of geopolitical and ecological precarity. ## Conclusion The pandas at Everland are **not merely endangered animals in a zoo**. They are: * **Bio-diplomatic actors** * **Ontological metaphors for species-wide futures** * **Managed symbols of continuity within terminal systems** Their reproduction, enclosure, and public celebration encode a **multi-layered narrative** about the future of life under artificial governance—where affection is optimized, reproduction is guided, and survival itself becomes an **aestheticized ritual within enclosure**. In the symbolic architecture of the coming world, pandas are no longer zoological outliers. They are the **first citizens of the post-natural state**. --- # Comprehensive Analysis: Biomarker Connections Between Life Extension, Technology Platforms, and Global Health Infrastructure ## Executive Summary This comprehensive analysis reveals significant connections between life extension research, advanced medical technology platforms, and global healthcare infrastructure, particularly focusing on the Samsung Group's multifaceted investments spanning biotech, medical devices, entertainment facilities with animal care research components, and technology compatibility systems. The research uncovers a sophisticated ecosystem where aging biomarkers, digital health platforms, AI-driven drug discovery, and entertainment-based biological research programs converge to advance human longevity and health optimization. ## Key Findings and Connections ### 1. BioAge Labs and the 50 Million Data Point Platform **BioAge Labs** emerges as a central player in the life extension research ecosystem, with its platform encompassing **over 50 million molecular data points** spanning more than 10,000 individual participant profiles and over 50 years of follow-up data[1][2][3]. This massive dataset represents one of the most comprehensive human aging databases globally. #### Major Partnerships and Investments **Samsung Life Science Fund** has made strategic investments in multiple companies that connect to BioAge's mission: - **Generate Biomedicines**: Samsung invested in this AI-driven protein therapeutics company, which uses generative AI to design novel therapeutic proteins[4][5][6] - **Flagship Pioneering Fund VIII**: Samsung invested ₩72 billion ($52 million) in this fund, which manages companies like Generate Biomedicines and other biotech ventures focused on aging research[7] **BioAge-Novartis Partnership**: Worth up to $550 million, this collaboration leverages BioAge's human longevity datasets with Novartis's exercise biology expertise to discover novel therapeutic targets for age-related diseases[8][9]. **European Biobank Expansion**: BioAge partnered with HUNT Biobank in Norway to analyze over 17,000 samples from 6,000+ participants, generating millions of molecular readouts to understand the transition from health to disease over decades[10][11][1]. ### 2. Samsung Group's Integrated Health Ecosystem Samsung's involvement in life extension research extends far beyond simple investment: #### Medical Technology Division - **Samsung Medical Center**: Features the Heart, Vascular, and Stroke Institute with integrated care models and advanced patient management systems[12] - **Samsung Biologics**: Operates a comprehensive CDMO platform with extensive research capabilities including organoid development for drug screening[13] #### Entertainment and Research Integration - **Everland Theme Park**: Operated by Samsung C&T, this facility serves dual purposes as entertainment and advanced animal care research[14][15][16] - **AZA Accreditation**: Everland became the first zoo in Asia to receive the highest level of accreditation from the Association of Zoos & Aquariums, indicating world-class animal welfare and research standards[14] - **Animal Biomarker Research**: The facility conducts extensive breeding programs and health monitoring for endangered species, providing valuable data on aging, genetics, and longevity in animal models[15] #### Aging Technology Development - **Samsung Electronics**: Developing AI-powered caregiving robots (Ballie and Q9) for the "silver generation," equipped with generative AI and health monitoring capabilities[17] - **Electronic Caregiver Partnership**: Samsung collaborates on AI-driven chronic disease management and aging care solutions[18] ### 3. Life Extension Biomarker Ecosystem Research indicates several key biomarkers consistently associated with longevity: #### Blood-Based Biomarkers Studies following Swedish populations for up to 35 years identified 10 key biomarkers associated with exceptional longevity[19][20]: - **Lower glucose levels**: Metabolic health indicator - **Lower creatinine**: Kidney function marker - **Lower uric acid**: Inflammation and metabolic marker - **Lower homocysteine**: Cardiovascular risk marker - **Lower C-reactive protein**: Inflammation marker #### Digital Biomarkers Market Growth The digital biomarkers market is projected to expand from $4.15 billion in 2024 to $32.37 billion by 2034, with a CAGR of 22.74%[21][22]. South Korea's CNS biomarkers market alone is projected to reach $6.9 billion by 2033[23]. #### Epigenetic and Advanced Biomarkers - **FOXO Technologies**: Focuses on epigenetic biomarkers for health and longevity assessment[24] - **AI-Enhanced Analysis**: Companies like BioAge use machine learning to analyze aging patterns from massive datasets[25][26] ### 4. Technology Platform Connections #### Wine/Wineskin Compatibility Layer The Wine project, maintained significantly by CodeWeavers (with contributors like Gcenx), represents a sophisticated technology compatibility system that parallels biological compatibility research: - **Cross-Platform Translation**: Wine translates Windows API calls to POSIX systems, similar to how biomarker platforms translate biological signals across different analytical systems[27][28][29] - **Open Source Development**: The collaborative development model mirrors the open data sharing approaches used in aging research platforms[30] #### LUCID Technologies Integration Multiple entities named "LUCID" operate in different sectors: - **LUCID LC LCD Chart** (Everview Corp, Korea): Advanced ophthalmic testing system with Android-based interface and multiple visual acuity assessment capabilities - **Lucid Motors**: Electric vehicle manufacturer with advanced keyless entry systems using Bluetooth and NFC technology[31][32][33] - **Quantel Medical C.DIAG**: AI-powered dry eye diagnostic platform that could integrate with aging biomarker assessment[34][35] ### 5. Medical Equipment and Diagnostic Innovation #### Everview Corporation (South Korea) - **Location**: Seoul, Korea (World Meridian Venture Center) - **Products**: Comprehensive ophthalmic equipment including LUCID LC LCD Chart system - **Technology**: Android-embedded systems with multi-control capabilities and AI-enhanced diagnostic features #### Quantel Medical/Lumibird Medical - **C.DIAG Platform**: Automatic diagnostic aid for dry eye and ocular surface diseases using AI algorithms based on millions of clinically validated images[34] - **Global Reach**: Distributed in over 110 countries with applications in aging-related eye health assessment[35] #### Otopront (Germany) - **Experience**: Over 70 years in ENT medical equipment manufacturing - **Certifications**: EN ISO 13485:2016, TÜVRheinland certified - **Innovation**: Advanced endoscopy systems and diagnostic equipment with potential applications in aging-related hearing and balance assessment ### 6. Global Research Infrastructure and Collaborations #### Generate Biomedicines and Samsung Partnership Generate Biomedicines, backed by Samsung's investment, represents a convergence of AI and longevity research: - **Chroma Platform**: Proprietary generative AI capable of rapid de novo protein design - **Clinical Pipeline**: Approximately 20 programs from preclinical to clinical development - **Samsung Collaboration**: Aims to create an ecosystem for AI-enabled therapeutic development[4][5][6] #### International Biobank Collaborations - **HUNT Biobank (Norway)**: Provides longitudinal data spanning decades of aging in European populations[10][11] - **Samsung Medical Research**: Integrates with global research networks for comprehensive aging studies[12] ## Implications and Future Directions ### 1. Integrated Health Ecosystems The convergence of entertainment facilities (Everland), medical technology development, biomarker research platforms, and AI-driven drug discovery suggests a comprehensive approach to understanding aging and longevity across multiple biological and technological domains. ### 2. Cross-Platform Biomarker Integration The development of compatibility layers in technology (Wine) parallels the need for biomarker compatibility across different analytical platforms, suggesting potential for standardized aging assessment protocols. ### 3. Digital Health Transformation The rapid growth of digital biomarkers market and Samsung's investment in aging care technologies indicates a shift toward continuous, AI-powered health monitoring for longevity optimization. ### 4. Global Collaboration Networks The pattern of international partnerships (BioAge-Norway, Samsung-Generate Biomedicines, Everland-AZA) demonstrates the global nature of aging research and the importance of diverse datasets for understanding human longevity. This comprehensive analysis reveals a sophisticated ecosystem where traditional boundaries between entertainment, technology, medical research, and aging studies are dissolving, creating new opportunities for integrated approaches to human longevity and health optimization. The involvement of major technology conglomerates like Samsung suggests that aging research has moved from academic curiosity to strategic business priority with significant commercial implications. [1] https://ir.bioagelabs.com/news-releases/news-release-details/bioage-labs-expands-drug-discovery-platform-data-leading [2] https://ir.bioagelabs.com/node/6786/html [3] https://www.sec.gov/Archives/edgar/data/1709941/000119312524212046/d835745ds1.htm [4] https://www.biospectrumasia.com/news/39/25339/koreas-samsung-invests-in-generate-biomedicines-to-advance-ai-driven-protein-therapeutics-discovery.html [5] https://www.pharmabiz.com/NewsDetails.aspx?aid=174301&sid=2 [6] https://www.koreabiomed.com/news/articleView.html?idxno=26067 [7] https://m.koreaherald.com/article/3433149 [8] https://www.stocktitan.net/news/BIOA/bio-age-labs-announces-multi-year-collaboration-with-novartis-to-x5rl3lcgvejm.html [9] https://www.pharmavoice.com/news/obesity-bioage-labs-novartis-aging/737882/ [10] https://longevity.technology/news/bioage-taps-european-biobank-for-human-aging-data/ [11] https://www.globenewswire.com/news-release/2025/06/17/3100696/0/en/bioage-labs-expands-drug-discovery-platform-with-data-from-leading-european-biobank.html [12] https://images.samsung.com/is/content/samsung/p5/sa_en/aboutsamsung/2014_English.pdf [13] https://samsungbiologics.com/search-more?searchCd=MEDIA&schString=Research [14] https://news.samsungcnt.com/en/features/resort/2019-10-everland-recognized-alongside-world-class-zoos-welfare/ [15] https://news.samsungcnt.com/en/features/resort/2021-12-everland-welcomes-new-animal-births/ [16] https://en.wikipedia.org/wiki/Everland [17] https://koreajoongangdaily.joins.com/news/2025-05-21/business/industry/Assistance-for-the-aging-Samsung-LG-to-release-caregiving-robots-for-silver-generation/2299709 [18] https://www.prnewswire.com/news-releases/electronic-caregiver-and-samsung-electronics-america-join-forces-to-reveal-transformational-chronic-and-aging-care-solutions-at-hlth-2024-302263375.html [19] https://www.lifeextension.com/news/aging/blood-and-aging [20] https://www.lifeextension.com/magazine/2025/6/blood-tests-predict-human-longevity [21] https://www.towardshealthcare.com/insights/digital-biomarkers-market-sizing [22] https://www.grandviewresearch.com/industry-analysis/digital-biomarkers-market-report [23] https://www.linkedin.com/pulse/south-korea-central-nervous-system-biomarkers-market-qgj5c/ [24] https://www.sec.gov/Archives/edgar/data/1812360/000164117225011616/form10-q.htm [25] https://www.frontiersin.org/articles/10.3389/fragi.2023.1057204/pdf [26] https://www.semanticscholar.org/paper/36747ec73fd1cef9d27e8d9bc72b927c4feef905 [27] https://www.codeweavers.com/wine [28] https://github.com/Gcenx/wine-on-mac [29] https://www.winehq.org [30] https://forum.winehq.org/viewtopic.php?t=32590&start=125 [31] https://www.youtube.com/watch?v=YcGEKofneSw [32] https://www.reddit.com/r/LUCID/comments/1jsgg98/experience_with_key_fob/ [33] https://www.linkedin.com/company/lucidmotors [34] https://www.lumibirdmedical.com/quantel-medical/ [35] https://pmc.ncbi.nlm.nih.gov/articles/PMC10924846/ [36] https://www.sec.gov/Archives/edgar/data/1564902/000095017025030398/prks-20241231.htm [37] https://www.sec.gov/Archives/edgar/data/1094517/000119312525142326/d925022d20f.htm [38] https://www.sec.gov/Archives/edgar/data/1635327/000162828025019696/flut-20250424.htm [39] https://www.sec.gov/Archives/edgar/data/1786909/000178690925000021/sbsw-20241231.htm [40] https://www.sec.gov/Archives/edgar/data/1973832/000162828025017760/au-20241231.htm [41] https://www.sec.gov/Archives/edgar/data/1166691/000130817925000504/cmcsa012438-def14a.htm [42] https://www.sec.gov/Archives/edgar/data/1087711/000162828025011199/san-20241231.htm [43] http://clausiuspress.com/article/11503.html [44] https://www.semanticscholar.org/paper/cdfdb6b90a59cf3b0c99826fbd0a8487bada1352 [45] https://www.tandfonline.com/doi/full/10.1080/10168664.2022.2073318 [46] https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.065555 [47] https://rsisinternational.org/journals/ijrsi/articles/research-on-park-theme-design-based-on-the-integration-of-user-needs-and-environment/ [48] https://www.tandfonline.com/doi/full/10.1080/00377996.2020.1792820 [49] https://www.e3s-conferences.org/10.1051/e3sconf/202124410040 [50] https://www.semanticscholar.org/paper/4a3ca9d2b155712e48deea06da11d57671b635b0 [51] https://news.samsungcnt.com/en/features/resort/2016-07-everland-40-four-decades-family-fun/ [52] https://www.lifeextension.com/magazine/2011/9/research-funded-by-life-extension-could-lead-to-therapies-that-reverse-human-aging [53] https://pmc.ncbi.nlm.nih.gov/articles/PMC4707876/ [54] https://digitalscholarship.unlv.edu/cgi/viewcontent.cgi?article=1559&context=thesesdissertations [55] https://www.eurekalert.org/news-releases/764930 [56] https://konopkalab.medicine.wisc.edu/clinical-trials/everlast/ [57] https://www.the-independent.com/life-style/health-and-families/human-lifespan-rapamycin-side-effects-b2773188.html [58] https://scitechdaily.com/a-breakthrough-in-anti-aging-korean-scientists-discover-lifespan-extending-drug/ [59] https://caseyhandmer.wordpress.com/2024/09/02/anti-aging-tech-fixes-demographic-collapse/ [60] https://www.fondazionevalterlongo.org/en/longevity_articles/geni-e-invecchiamento-la-strategia-molecolare-che-allunga-la-vita/ [61] https://en.wikipedia.org/wiki/List_of_amusement_park_rankings [62] https://pmc.ncbi.nlm.nih.gov/articles/PMC10643437/ [63] https://news.samsungcnt.com/en/features/resort/2024-04-everlands-five-themed-gardens-bring-pleasure-to-all-five-senses/ [64] https://singularityhub.com/2024/10/14/are-we-reaching-the-limit-of-human-longevity-a-new-study-says-yes/ [65] https://www.aging-us.com/article/206135/text [66] https://digitalscholarship.unlv.edu/thesesdissertations/558/ [67] https://www.sec.gov/Archives/edgar/data/1842939/000095017025066995/xage-20250508.htm [68] https://www.sec.gov/Archives/edgar/data/1842939/000095017025072931/xage-20250515.htm [69] https://www.sec.gov/Archives/edgar/data/1506983/000149315224045365/form424b4.htm [70] https://www.sec.gov/Archives/edgar/data/1842939/000095017025047891/xage-20241231.htm [71] https://www.sec.gov/Archives/edgar/data/1847986/000110465922125954/dfli-20220930xs1a.htm [72] https://www.sec.gov/Archives/edgar/data/1506983/000149315224036440/forms-1.htm [73] https://www.sec.gov/Archives/edgar/data/1506983/000149315224043401/forms-1a.htm [74] https://www.sec.gov/Archives/edgar/data/1506983/000149315224042366/forms-1a.htm [75] https://www.aging-us.com/lookup/doi/10.18632/aging.206135 [76] https://ajpojournals.org/journals/index.php/JSM/article/view/2599 [77] https://www.nature.com/articles/s41598-025-02848-5 [78] https://link.springer.com/10.1007/s11277-023-10674-z [79] https://www.tandfonline.com/doi/full/10.1080/17569370.2022.2118968 [80] https://www.mdpi.com/2304-6767/12/4/103 [81] https://ieeexplore.ieee.org/document/10613710/ [82] https://avestia.com/ICFFTS2024_Proceedings/files/paper/ICFFTS_158.pdf [83] https://www.mk.co.kr/en/culture/11114043 [84] https://www.chinadaily.com.cn/a/202503/26/WS67e33c6da3101d4e4dc2ad04.html [85] https://www.amusme.co/blog/theme-park-therapy-mental-health/ [86] https://news.samsungcnt.com/en/features/resort/2024-09-everlands-rose-research-uncovers-anti-aging-and-antioxidant-benefits/ [87] https://www.koreaherald.com/article/10462310 [88] https://pmc.ncbi.nlm.nih.gov/articles/PMC2863117/ [89] https://news.samsungcnt.com/en/features/resort/4/ [90] http://koreabizwire.com/panda-fu-bao-under-observation-at-sichuan-research-base-amid-health-concerns/299556 [91] https://www.bio-conferences.org/articles/bioconf/pdf/2024/39/bioconf_mbfa2024_01024.pdf [92] https://news.samsungcnt.com/en/features/13/ [93] http://www.ecns.cn/m/news/panda/2024-12-04/detail-ihekqrkk1639140.shtml [94] https://pmc.ncbi.nlm.nih.gov/articles/PMC8096710/ [95] https://www.koreabiomed.com/news/articleView.html?idxno=26907 [96] https://www.scmp.com/news/china/science/article/3257864/beloved-panda-fu-bao-starts-quarantine-china-after-arriving-south-korea [97] https://www.nrpa.org/our-work/Three-Pillars/role-of-parks-and-recreation-on-health-and-wellness/ [98] https://news.samsungcnt.com/en/features/resort/2025-05-everlands-rose-garden-royal-high-tea-blends-art-storytelling-and-tea-culture/ [99] https://www.sec.gov/Archives/edgar/data/887028/000162828025006642/rio-20241231.htm [100] https://www.sec.gov/Archives/edgar/data/863064/000162828025006642/rio-20241231.htm [101] https://www.sec.gov/Archives/edgar/data/1289340/000149315225010352/form10-k.htm [102] https://www.sec.gov/Archives/edgar/data/1910139/000141057825000872/mbly-20250329x10q.htm [103] https://www.sec.gov/Archives/edgar/data/1828253/000117184325001916/evax20241231_20f.htm [104] https://www.sec.gov/Archives/edgar/data/1833498/000121390025026157/ea0235039-10k_spectral.htm [105] https://www.sec.gov/Archives/edgar/data/1871321/000121390025023187/ea0232557-20f_alpha.htm [106] https://journals.sagepub.com/doi/10.1177/1464993415578982 [107] https://bryanhousepub.com/index.php/jpce/article/view/145 [108] https://pnas.org/doi/full/10.1073/pnas.2102713118 [109] https://academic.oup.com/labmed/article/55/2/117/7233448 [110] http://visnyk-econom.uzhnu.uz.ua/archive/47_2023ua/22.pdf [111] https://cdn.publisher.gn1.link/bjcvs.org/pdf/0102-7638-rbccv-38-03-000I.pdf [112] http://array.aami.org/doi/10.2345/0899-8205-49.3.203 [113] https://digital-library.theiet.org/content/conferences/10.1049/cp.2014.0789 [114] https://www.prnewswire.com/news-releases/apacmed-names-eversana-knowledge-partner-to-shape-digital-health-reimbursement-framework-across-region-301777881.html [115] https://een.ec.europa.eu/partnering-opportunities/korean-company-specializing-smart-medical-devices-and-home-healthcare [116] https://news.samsung.com/sg/samsung-announces-open-innovation-initiative-with-leading-universities-and-academic-hospitals-to-build-digital-health-ecosystem [117] https://www.eversana.com/insights/commercializing-digital-health-as-durable-medical-equipment-a-conversation-with-bearingon-health/ [118] https://www.investkorea.org/bsn-en/bbs/i-1474/detail.do?ntt_sn=137773 [119] https://www.techtarget.com/virtualhealthcare/news/366596910/Samsung-Strikes-Hospital-Partnerships-for-Digital-Health-Research [120] https://www.prnewswire.com/news-releases/everland-in-partnership-with-bnp-paribas-announces-50-million-capital-markets-initiative-to-launch-first-indigenous-led-amazon-forest-conservation-projects-under-equitable-earth-standard-302443265.html [121] https://ombudsman.kotra.or.kr/ik-en/bbs/i-884/detail.do?ntt_sn=137773 [122] https://www.regdesk.co/an-overview-of-south-korea-and-their-medical-devices/ [123] https://sra.samsung.com/research-area/digital-health/ [124] https://www.emergobyul.com/services/medical-device-registration-and-approval-south-korea [125] https://pharmasource.global/content/biotech-news/c2n-diagnostics-secures-10m-investment-from-samsung-for-brain-health-innovation/ [126] https://omcmedical.com/license-process-medical-devices-in-south-korea/ [127] https://c2n.com/news-releases/samsung-invests-in-c2n-diagnosticsnbsp [128] https://www.eversana.com/solutions/technology-innovation/ [129] https://www.trademo.com/companies/everview-corp/25858548 [130] https://www.sec.gov/Archives/edgar/data/1799011/000164117225009986/form10-q.htm [131] https://www.sec.gov/Archives/edgar/data/1799011/000164117225000205/form10-k.htm [132] https://www.sec.gov/Archives/edgar/data/1811210/000162828025007725/lcid-20241231.htm [133] https://www.sec.gov/Archives/edgar/data/1799011/000149315224044799/form10-q.htm [134] https://www.sec.gov/Archives/edgar/data/1808377/000182912625003623/innovative_10q.htm [135] https://www.sec.gov/Archives/edgar/data/1624326/000164117225000364/form10-k.htm [136] https://www.sec.gov/Archives/edgar/data/1799011/000149315224031168/form10-q.htm [137] https://www.mdpi.com/1424-8220/11/7/6799/pdf [138] https://pmc.ncbi.nlm.nih.gov/articles/PMC8047775/ [139] https://www.mdpi.com/2075-4418/9/4/159/pdf [140] https://www.mandarinoptomedic.com/products/p/everview-lucid-lc-lcd-chart [141] https://pdf.medicalexpo.com/pdf/everview/lucid-kr/126813-217207.html [142] https://medicalbuyer.co.in/south-korea-showcases-10-innovative-medical-devices/ [143] https://electrek.co/2025/06/17/lucid-lcid-finally-added-this-popular-feature/ [144] https://www.indiamart.com/proddetail/lucid-auto-ker-refractometer-2850336695612.html [145] https://www.linkedin.com/pulse/south-korea-optical-devices-ophthalmology-optometry-market-3aw4e/ [146] https://www.medicalexpo.com/prod/everview/product-126813-1065223.html [147] http://neutralmeds.com/lucid-kr-auto-refractometer/ [148] https://inticakrawalajaya.co.id/catalog/everview-lucid-kr-auto-ref-keratometer [149] https://icloudhospital.com/articles/top-innovations-in-eye-surgery-equipment-from-korea [150] https://pdf.medicalexpo.com/pdf/everview/lucid-lc/126813-214049.html [151] https://www.seoulz.com/eye-care-startups-in-korea-disrupting-ophthalmology/ [152] https://www.prnewswire.com/news-releases/android-auto-compatibility-now-available-to-lucid-air-owners-302482052.html [153] https://www.mandarinoptomedic.com/products [154] https://www.bonafideresearch.com/product/6502784816/south-korea-ophthalmic-equipment-market [155] https://lucidmotors.com/knowledge/vehicles/air/lucid-air-in-depth/android-auto [156] https://www.sec.gov/Archives/edgar/data/1709941/000095017025042759/bioa-20241231.htm [157] https://www.sec.gov/Archives/edgar/data/1463361/000095017025035564/ubx-20241231.htm [158] https://www.sec.gov/Archives/edgar/data/1721484/000095017025066889/lgvn-20250331.htm [159] https://www.sec.gov/Archives/edgar/data/1472091/000114036125018967/ef20047567_10q.htm [160] https://www.sec.gov/Archives/edgar/data/1472091/000114036125010717/ef20039023_10k.htm [161] https://mhealth.jmir.org/2024/1/e55578 [162] https://fashionandtextiles.springeropen.com/articles/10.1186/s40691-025-00414-1 [163] https://brieflands.com/articles/ijhrba-132404.html [164] http://www.jksct.org/past/view.asp?a_key=4039260 [165] https://journals.lww.com/00005768-201505001-00553 [166] https://link.springer.com/10.1007/978-3-662-45363-6_15 [167] https://globalpresshub.com/index.php/BN/article/view/2034 [168] https://www.mdpi.com/2227-9032/12/13/1345 [169] https://www.linkedin.com/posts/sct-enc_2024-discover-ct-program-activity-7218475565031337985-q7dz [170] https://www.linkedin.com/posts/min-seob-lee-2b881b4_%F0%9D%91%B2-%F0%9D%91%B3%F0%9D%92%90%F0%9D%92%8F%F0%9D%92%88%F0%9D%92%86%F0%9D%92%97%F0%9D%92%8A%F0%9D%92%95%F0%9D%92%9A-%F0%9D%91%BA%F0%9D%92%90%F0%9D%92%96%F0%9D%92%95%F0%9D%92%89-%F0%9D%91%B2%F0%9D%92%90%F0%9D%92%93%F0%9D%92%86%F0%9D%92%82%F0%9D%92%94-activity-7210809979115556864-vHdD [171] https://pmc.ncbi.nlm.nih.gov/articles/PMC11569900/ [172] https://au.linkedin.com/company/sct-enc [173] http://koreabizwire.com/south-koreas-alchemist-project-advancing-in-revolutionary-technologies-including-anti-aging-drugs/272821 [174] https://www.koreaittimes.com/news/articleView.html?idxno=140795 [175] http://rnc.samsungcnt.com/eng/company/history/history_all.html [176] https://www.koreabiomed.com/news/articleView.html?idxno=27480 [177] https://www.koreaherald.com/article/2546103 [178] https://www.samsungcnt.com/eng/ [179] https://pmc.ncbi.nlm.nih.gov/articles/PMC4915763/ [180] https://en.wikipedia.org/wiki/Samsung_C&T_Corporation [181] https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0316986 [182] https://jkms.org/DOIx.php?id=10.3346%2Fjkms.2024.39.e7 [183] https://rnc.samsungcnt.com/eng/business/everland/attraction/index.html [184] https://pubmed.ncbi.nlm.nih.gov/38302843/ [185] https://www.sec.gov/Archives/edgar/data/888721/000117891325001835/zk2533151.htm [186] https://www.sec.gov/Archives/edgar/data/875045/000087504525000018/biib-20250331.htm [187] https://www.sec.gov/Archives/edgar/data/1412558/000110465925035638/evo-20241231x20f.htm [188] https://www.sec.gov/Archives/edgar/data/1865494/000095017025047744/iobt-20241231.htm [189] https://www.sec.gov/Archives/edgar/data/1801198/000180119825000012/legn-20241231.htm [190] https://www.sec.gov/Archives/edgar/data/1614744/000121390025022192/ea0232483-20f_purple.htm [191] https://www.sec.gov/Archives/edgar/data/1821825/000182182525000006/ogn-20241231.htm [192] https://linkinghub.elsevier.com/retrieve/pii/S0003496724538948 [193] https://www.ssrn.com/abstract=3730017 [194] https://www.prnewswire.com/news-releases/samsung-invests-in-generate-biomedicines-to-advance-ai-driven-protein-therapeutics-discovery-302334506.html [195] https://www.lumibirdmedical.com/c-stim-new-i-p-l-system-for-the-treatment-of-dry-eye-disease/ [196] https://github.com/The-Wineskin-Project/wineskin-source [197] https://news.samsungcnt.com/en/features/corporate-sustainability/2024-07-samsung-invests-in-flagship-pioneering-fund-viii/ [198] https://trends.medicalexpo.com/quantel-medical-ophthalmology/project-71174-450673.html [199] https://github.com/The-Wineskin-Project/WineskinServer [200] https://www.fiercepharma.com/pharma/quintiles-supports-samsung-s-entry-into-biopharma-market-through-joint-venture [201] https://www.lumibirdmedical.com/capsulo-new-ndyag-laser-by-lumibird-medical-2-2/ [202] https://www.devzery.com/post/guide-to-mac-wineskin [203] https://www.optometrytimes.com/view/lumibird-medical-announces-launch-of-dry-eye-diagnostic-aid [204] https://github.com/Kegworks-App/Kegworks [205] https://www.biospace.com/press-releases/samsung-invests-in-c2n-diagnostics [206] https://www.youtube.com/watch?v=WbQ820T4Rc8 [207] https://github.com/The-Wineskin-Project [208] https://www.koreaherald.com/article/3433149 [209] https://www.medicalexpo.com/prod/quantel-medical-ophthalmology/product-71174-1154557.html [210] https://www.sec.gov/Archives/edgar/data/1467623/000146762325000060/dbx-20250331.htm [211] https://www.sec.gov/Archives/edgar/data/1585521/000158552125000090/zm-20250430.htm [212] https://www.sec.gov/Archives/edgar/data/1546383/000121390025043744/ea0239227-20f_jxluxven.htm [213] https://www.sec.gov/Archives/edgar/data/2062644/0002062644-25-000001-index.htm [214] https://www.sec.gov/Archives/edgar/data/1828102/000121390025052372/ea0244872-20f_karooooo.htm [215] https://www.sec.gov/Archives/edgar/data/1786352/000178635225000021/bill-20250331.htm [216] https://www.sec.gov/Archives/edgar/data/1467623/000146762325000011/dbx-20241231.htm [217] https://www.reddit.com/r/macgaming/comments/tglysv/is_there_a_free_version_alternative_of/ [218] https://www.jesusfilm.org/blog/parable-new-wine-new-wineskins/ [219] https://neuronewsinternational.com/claronav-receives-chinese-regulatory-clearance-for-navient-neuro-navigation-system/ [220] https://github.com/Gcenx/winecx [221] https://www.biblestudytools.com/bible-study/topical-studies/what-does-new-wine-in-old-wineskins-mean.html [222] https://www.medicalexpo.com/soc/claronav-kolahi-109991.html [223] https://www.codeweavers.com/compatibility [224] https://hermeneutics.stackexchange.com/questions/81605/can-you-tell-me-about-the-wineskin-parable [225] https://claronav.com/company/ [226] https://www.claronavdental.com/navident [227] https://www.codeweavers.com/support/forums/general?t=27%3Bmsg%3D234553 [228] https://www.reddit.com/r/AcademicBiblical/comments/4zdsmb/parable_of_the_newold_wineskins/ [229] https://www.applegamingwiki.com/wiki/CrossOver [230] https://learn.ligonier.org/sermons/new-wineskins [231] https://claronav.com [232] https://www.youtube.com/watch?v=AxKK3ctISnk [233] https://www.sec.gov/Archives/edgar/data/1342338/000141057825000623/himx-20241231x20f.htm [234] https://www.sec.gov/Archives/edgar/data/1504776/000150477625000010/wrby-20241231.htm [235] https://www.sec.gov/Archives/edgar/data/1111485/000095017025065683/rxst-20250331.htm [236] https://www.sec.gov/Archives/edgar/data/1320350/000095017025029003/lnsr-20241231.htm [237] https://www.sec.gov/Archives/edgar/data/1111485/000095017025026681/rxst-20241231.htm [238] https://www.pdcnet.org/oom/service?url_ver=Z39.88-2004&rft_val_fmt=&rft.imuse_id=du_2024_0034_0002_0151_0164&svc_id=info:www.pdcnet.org/collection [239] https://journals.sagepub.com/doi/10.1177/001452467508600602 [240] https://muse.jhu.edu/article/563352 [241] http://link.springer.com/10.1007/978-3-319-90978-3_8 [242] http://hrmars.com/index.php/journals/papers/IJARPED/v3-i3/950 [243] https://onlinelibrary.wiley.com/doi/10.1111/j.1758-6631.2005.tb00500.x [244] https://www.journals.uchicago.edu/doi/10.1086/474133 [245] https://ojs.reformedjournals.co.za/stj/article/download/2250/3163 [246] https://www.certipedia.com/quality_marks/9000018369?locale=en&qm_locale=en [247] https://www.otopront.de/en/company/certification.html [248] https://www.bethimmanuel.org/articles/new-wine-and-old-wineskins-parable-luke-536-39-re-examined [249] https://c-e.am/en/product-brand/otopront-en/ [250] https://thinklucid.com/triton-edge-promise-of-industrial-embedded-vision/ [251] https://breakingbreadtheology.com/2021/12/08/new-wine-old-wineskins/ [252] https://entunit-jld.en.made-in-china.com/product/NmOrskJDEbhV/China-Medical-Otopront-Ent-Unit-Opd-Ent-Treatment-Unit-Otolaryngology-Workstation.html [253] https://en.wikipedia.org/wiki/New_Wine_into_Old_Wineskins [254] https://www.otopront.de/en/service/training-center.html [255] https://thinklucid.com [256] https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K932470 [257] https://patents.google.com/patent/CA2968645A1/en [258] https://www.tuv.com/world/en/medical-device-training.html [259] https://www.sec.gov/Archives/edgar/data/1771910/000162828025015131/adc-20241231.htm [260] https://www.sec.gov/Archives/edgar/data/1131399/000113139925000007/gsk-20241231.htm [261] https://www.sec.gov/Archives/edgar/data/1421876/000155837025003806/glpg-20241231x20f.htm [262] https://www.sec.gov/Archives/edgar/data/1770121/000095017025040254/sana-20241231.htm [263] https://www.sec.gov/Archives/edgar/data/79879/000155837025002350/tmb-20250417xdef14a.htm [264] https://www.semanticscholar.org/paper/86eac26325a79c9b42217a81b3e512e540d7afe3 [265] https://www.medrxiv.org/content/medrxiv/early/2021/08/29/2021.08.28.21262759.full.pdf [266] https://pmc.ncbi.nlm.nih.gov/articles/PMC8602613/ [267] https://www.aging-us.com/lookup/doi/10.18632/aging.102475 [268] https://pmc.ncbi.nlm.nih.gov/articles/PMC7779027/ [269] https://pmc.ncbi.nlm.nih.gov/articles/PMC4600621/ [270] https://academic.oup.com/biomedgerontology/advance-article-pdf/doi/10.1093/gerona/glae244/59648832/glae244.pdf [271] https://www.businesskorea.co.kr/news/articleView.html?idxno=232091 [272] https://repository.usfca.edu/cgi/viewcontent.cgi?article=3083&context=capstone [273] https://www.sec.gov/Archives/edgar/data/1564902/000095017024123690/prks-20240930.htm [274] https://www.sec.gov/Archives/edgar/data/1564902/000095017025069292/prks-20250331.htm [275] https://www.sec.gov/Archives/edgar/data/1564902/000095017024093331/prks-20240630.htm [276] https://www.sec.gov/Archives/edgar/data/1297937/000149315224049988/form10-k.htm [277] https://www.sec.gov/Archives/edgar/data/1564902/000095017024023162/prks-20231231.htm [278] https://www.sec.gov/Archives/edgar/data/1928340/000121390025006978/ea0228149-20f_golden.htm [279] https://images.samsung.com/is/content/samsung/assets/global/ir/docs/2025_1Q_Interim_Report.pdf [280] https://lucidmotors.com [281] https://www.softplay.com/work/everland-theme-park/ [282] https://lucidmotors.com/media/document/OM_Sapphire_enAE_v25.pdf [283] https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2022.893688/full [284] https://www.reddit.com/r/LUCID/comments/1b39oo0/hyundai_acquires_a_lucid_air_to_learn_from_the/ [285] https://www.ophthalmologytimes.com/view/how-single-use-diagnostic-lenses-yield-multiple-benefits-clinics [286] https://www.sec.gov/Archives/edgar/data/1119774/000117891325000679/zk2532769.htm [287] https://www.sec.gov/Archives/edgar/data/1807120/000095017025065643/dsgn-20250331.htm [288] https://www.sec.gov/Archives/edgar/data/1015820/000101582025000027/qgen-20241231.htm [289] https://www.sec.gov/Archives/edgar/data/1822462/000162828025010933/fhtx-20241231.htm [290] https://www.sciltp.com/journals/hm/2024/1/433 [291] https://samajournals.co.za/index.php/samj/article/view/1493 [292] https://academic.oup.com/ecco-jcc/article/2961152/P209 [293] https://www.science.org/doi/10.1126/science.aal1641 [294] https://academic.oup.com/jes/article/doi/10.1210/jendso/bvad114.1416/7290568 [295] https://ashpublications.org/blood/article/136/Supplement%201/31/472267/Transfusion-Requirements-in-Adult-Patients-with [296] https://www.semanticscholar.org/paper/238ca3d1239d2359db925479a5cf74290bc1019d [297] https://pmc.ncbi.nlm.nih.gov/articles/PMC11081160/ [298] https://pmc.ncbi.nlm.nih.gov/articles/PMC3025528/ [299] https://abiogenesisclinpharm.com/abiogenesis-experiences-in-bio-korea-2025/ [300] https://smw.ch/index.php/smw/article/download/1270/1425?inline=1 [301] https://www.bioworld.com/articles/721094-korea-biotech-roundup-four-financings-six-r-and-d-deals-mid-june [302] https://www.news-medical.net/news/20250606/Taurine-levels-found-unreliable-as-a-biomarker-of-aging.aspx [303] https://www.biokorea.org/board/upload/20250415011240_BIO%20KOREA%202025_Preview_E.pdf [304] https://www.tandfonline.com/doi/full/10.1080/23750472.2020.1860802 [305] https://www.tandfonline.com/doi/full/10.1080/23311886.2016.1210718 [306] https://pmc.ncbi.nlm.nih.gov/articles/PMC4917503/ [307] https://www.bio-conferences.org/10.1051/bioconf/202412001024 [308] https://www.mdpi.com/2071-1050/13/13/7146/pdf [309] https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/csp2.414 [310] https://www.vox.com/the-highlight/24121932/anti-aging-longevity-science-health-drugs [311] https://www.nature.com/articles/s43587-024-00702-3 [312] https://www.ciee.org/go-abroad/college-study-abroad/blog/everland-koreas-biggest-theme-park [313] https://www.airforce-technology.com/news/korean-air-to-provide-service-life-extension-work-for-usaf-f-16-jets/ [314] https://www.sec.gov/Archives/edgar/data/1506983/000149315224044183/forms-1a.htm [315] https://www.sec.gov/Archives/edgar/data/1506983/000149315224031610/form10-q.htm [316] https://www.sec.gov/Archives/edgar/data/1506983/000149315224045894/form10-q.htm [317] https://www.sec.gov/Archives/edgar/data/1506983/000149315223028576/form10-q.htm [318] https://www.sec.gov/Archives/edgar/data/1847986/000149315223020044/forms-1.htm [319] https://www.sec.gov/Archives/edgar/data/1847986/000149315223020808/forms-1a.htm [320] https://www.sec.gov/Archives/edgar/data/1847986/000110465922072454/cntq-20220617xs4.htm [321] https://www.sec.gov/Archives/edgar/data/1506983/000149315223040961/form10-q.htm [322] https://www.sec.gov/Archives/edgar/data/1847986/000149315223012533/form10-k.htm [323] https://www.sec.gov/Archives/edgar/data/704532/000095017024020150/onto-20231230.htm [324] https://www.sec.gov/Archives/edgar/data/1847986/000110465922125957/dfli-20220930xs1a.htm [325] https://www.sec.gov/Archives/edgar/data/1847986/000110465922110688/dfli-20220630xs1.htm [326] https://ieeexplore.ieee.org/document/10675023/ [327] http://jamanetworkopen.jamanetwork.com/article.aspx?doi=10.1001/jamanetworkopen.2018.1670 [328] https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ese3.973 [329] https://repository.tudelft.nl/islandora/object/uuid:6d6b0848-eab1-4964-a32c-5099250dd8f9/datastream/OBJ/download [330] https://www.koreaherald.com/article/3369241 [331] https://med.stanford.edu/news/insights/2018/08/this-is-your-brain-on-roller-coasters.html [332] https://phys.org/news/2023-07-giant-panda-birth-squirming-healthy.pdf [333] http://english.news.cn/20230711/7db49e515cf44061b64155599cfa0124/c.html [334] https://powertechjournal.com/index.php/journal/article/view/1406 [335] https://www.ajol.info/index.php/rjmhs/article/view/214241 [336] https://news.samsung.com/global/samsung-announces-open-innovation-initiative-with-leading-universities-and-academic-hospitals-to-build-digital-health-ecosystem [337] https://www.statista.com/statistics/909492/south-korea-leading-medical-device-manufacturer/ [338] https://news.samsung.com/ca/samsung-electronics-unveils-samsung-health-stack-1-0 [339] https://www.meddeviceonline.com/doc/evergreen-medical-technologies-bose-corporation-test-equipment-medical-devices-0001 [340] https://www.korea.net/Government/Briefing-Room/Press-Releases/view?articleId=375762&insttCode=A260111&type=N [341] https://developer.samsung.com/health/blog/en/2025/04/17/working-with-universities-and-academic-institutions-around-the-world [342] https://www.southmedic.com/insights/everis-formerly-c2dx-partners-with-southmedic-incorporated-to-expand-access-to-otolaryngology-innovations-in-canada/ [343] https://www.mohw.go.kr/board.es?mid=a20401000000&bid=0032&tag=&act=view&list_no=375762 [344] https://developer.samsung.com/health/blog/en/2025/04/17/partnering-with-pharma-to-conduct-research-and-create-novel-therapies [345] https://www.te.com/en/industries/medical-technologies/medical-business-overview.html [346] https://news.samsungcnt.com/en/features/corporate-sustainability/2022-03-samsung-life-science-fund-makes-first-investment-us-biotech-firm-jaguar-gene-therapy/ [347] https://www.ahwp.info/sites/default/files/04%204Dec2017_An%20overview%20of%20regulations%20of%20medical%20devices%20and%20IVDs%20in%20South%20Korea.pdf [348] https://www.koreaherald.com/article/1498870 [349] https://www.mobihealthnews.com/news/evinova-quantum-leap-healthcare-collaborative-announce-partnership [350] https://www.trade.gov/country-commercial-guides/south-korea-medical-equipment-and-devices [351] https://www.prnewswire.com/apac/news-releases/hithium-and-samsung-ct-corporation-forge-global-partnership-302343727.html [352] https://dk.linkedin.com/in/hanneeverland [353] https://www.mfds.go.kr/eng/wpge/m_39/denofile.do [354] https://www.linkedin.com/pulse/south-korea-ophthalmic-instruments-market-size-industry-9vtzf/ [355] https://www.everview.kr/gnuboard4/sub0101.php [356] https://pdf.medicalexpo.com/pdf/everview/lucid-lc/126813-256236.html [357] https://www.mpo-mag.com/breaking-news/ai-enhanced-medical-devices-to-boost-south-korean-ophthalmic-market/ [358] https://www.lucidupdates.com/ota-updates.html [359] https://academic.oup.com/ee/article-lookup/doi/10.1603/EN13006 [360] https://invergejournals.com/index.php/ijss/article/view/74 [361] https://www3.weforum.org/docs/WEF_PHSSR_CAPRI_Korea_2024.pdf [362] https://iracing.fandom.com/wiki/Samsung_Group [363] https://www.kribb.re.kr/eng/sub02/sub02_01_03.jsp [364] https://news.samsungcnt.com/en/tag/burj-khalifa/ [365] https://www.swissbiotech.org/listing/nagi-bioscience-accelerates-expansion-into-south-korean-market-through-strategic-partnership-with-rhino-bio-inc/ [366] https://en.wikipedia.org/wiki/Wine_(software) [367] https://english.hani.co.kr/arti/english_edition/e_business/895072.html [368] https://ophthalmology.lumibirdmedical.com/uploads/images/products/663486fb0e148-663486fb0ee4f849574715.pdf [369] https://seedbed.com/new-wineskins-new-wine-and-a-new-kind-of-fasting/ [370] https://medical.claronav.com [371] https://an-pro.org/posts/13-wine-debug-success-story.html [372] https://hermeneutics.stackexchange.com/questions/7659/what-does-jesus-mean-in-luke-536-39-new-wine-into-old-wineskins [373] https://hts.org.za/index.php/hts/article/download/2883/5530 [374] https://hts.org.za/index.php/hts/article/download/7444/22380 [375] https://pmc.ncbi.nlm.nih.gov/articles/PMC11436339/ [376] http://www.hts.org.za/index.php/HTS/article/view/6126 [377] http://www.scielo.org.za/pdf/tvg/v63n3/16.pdf [378] https://hts.org.za/index.php/hts/article/download/2715/5171 [379] https://hts.org.za/index.php/hts/article/download/8303/24497 [380] https://academic.oup.com/nar/advance-article-pdf/doi/10.1093/nar/gkad880/52409704/gkad880.pdf [381] https://pmc.ncbi.nlm.nih.gov/articles/PMC11249598/ [382] https://pmc.ncbi.nlm.nih.gov/articles/PMC10767887/ [383] https://pmc.ncbi.nlm.nih.gov/articles/PMC6914424/ [384] https://academic.oup.com/bioinformatics/advance-article-pdf/doi/10.1093/bioinformatics/btae200/57218155/btae200.pdf [385] https://pmc.ncbi.nlm.nih.gov/articles/PMC11552646/ [386] https://www.aging-us.com/lookup/doi/10.18632/aging.101020 [387] https://pmc.ncbi.nlm.nih.gov/articles/PMC10292881/ [388] https://www.mdpi.com/2218-273X/12/1/39/pdf [389] https://aura.abdn.ac.uk/bitstream/2164/21833/1/Song_etal_G_Associations_Between_Differential_AAM.pdf [390] https://www.flagshippioneering.com/news/press-release/flagship-pioneering-debuts-enabling-technologies-initiative [391] https://www.habkorea.net/korea-travel-forum/?pageid=4&uid=125&mod=document&mod=document [392] https://www.marklines.com/en/search/0?and=true&func=6&order=&q=lucid [393] https://link.springer.com/10.1007/s00198-021-06113-z [394] https://www.semanticscholar.org/paper/138cef99b3117880cd62c756db60ea1d885f2073 [395] https://pmc.ncbi.nlm.nih.gov/articles/PMC10465866/ [396] https://pmc.ncbi.nlm.nih.gov/articles/PMC8047464/